Kukkutanda Basti (ALBU-PRO Bio-Enemata) vs. Intravenous Albumin in the Management of Hypoalbuminemia: A Comparative Pilot Clinical Study
DOI:
https://doi.org/10.63001/tbs.2026.v21.i01.pp1015-1025Keywords:
Kukkutanda Basti,Abstract
Ayurveda offers a wide spectrum of therapeutic modalities, among which Basti therapy plays
a significant role due to its systemic action through rectal administration. Kukkutanda Basti, a formulation
derived from egg yolk, has been traditionally used to enhance nutritional status. Considering the high cost,
limited efficacy, and adverse reactions associated with intravenous albumin therapy, there is a growing
need to explore affordable and safer Ayurvedic alternatives for managing hypoalbuminemia.
Aim: To evaluate the pharmaceutical characteristics and clinical efficacy of ALBU-PRO Bio-Enemata
(Kukkutanda Basti) and to compare its therapeutic outcomes with standard intravenous albumin
supplementation in patients with hypoalbuminemia.



















